GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » Current Deferred Revenue

Hubei Guangji Pharmaceutical Co (SZSE:000952) Current Deferred Revenue : ¥0.0 Mil (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Hubei Guangji Pharmaceutical Co's current deferred revenue for the quarter that ended in Mar. 2025 was ¥0.0 Mil.

Hubei Guangji Pharmaceutical Co Current Deferred Revenue Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co Current Deferred Revenue Chart

Hubei Guangji Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hubei Guangji Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hubei Guangji Pharmaceutical Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Guangji Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Executives
Zou Guang Ming Independent director
Guo Shao Zhi Executives
Zhang Bin Director
Guo Wen Chao Supervisors
Sun Zhen Hua Director
Liao Qing Jiang Director
Wang Xin Directors, executives
Hu Feng Lei Supervisors
Ruan Zhong Yi Executives
Zhang Ping Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines